Similarities and Differences among Antipsychotics

Journal of Clinical Psychiatry

Volumn 64, Issue SUPPL. 17, 2003, Pages 7-10

  Tamminga, Carol A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CLOZAPINE; DOPAMINE RECEPTOR; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN RECEPTOR; ZIPRASIDONE;

AGRANULOCYTOSIS; AKATHISIA; COGNITIVE DEFECT; CONFERENCE PAPER; DIABETES MELLITUS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; DYSLIPIDEMIA; GALACTORRHEA; HEADACHE; HEART DISEASE; HUMAN; HYPERPROLACTINEMIA; HYPERTENSION; LONG QT SYNDROME; METABOLIC DISORDER; MOTOR DYSFUNCTION; NEGATIVE SYNDROME; PARKINSONISM; PRIORITY JOURNAL; PROGNOSIS; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; SEDATION; SEIZURE; SOMNOLENCE; SYMPTOMATOLOGY; TACHYCARDIA; TREATMENT PLANNING; WEIGHT GAIN;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; DIBENZOTHIAZEPINES; HALOPERIDOL; HUMANS; PIPERAZINES; PIRENZEPINE; QUINOLONES; RISPERIDONE; SCHIZOPHRENIA; THIAZOLES;

EID: 0348011628     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)

1. Tamminga CA. Principles of the pharmacotherapy of schizophrenia. In: Charney DS, Nestler EJ, Bunney BS, eds. Neurobiology of Mental Illness, pt 3: Psychoses. 2nd ed. New York, NY: Oxford University Press; 1999
2. Van Putten T, Marder SR, Wirshing WC, et al. Neuroleptic plasma levels. Schizophr Bull 1991;17:197-216
3. Zimbroff DL, Kane JM, Tamminga CA, et al. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Am J Psychiatry 1997;154:782-791
4. 2 receptor occupancy with low-dose haloperidol treatment: a PET study. Am J Psychiatry 1996;153:948-950
5. Lahti AC, Holcomb HH, Weiler MA, et al. Functional effects of antipsychotic drugs: comparing clozapine with haloperidol. Biol Psychiatry 2003;53:601-608
6. Nyberg S, Farde L, Erikssen L. 5-HT2 and D2 dopamine receptor occupancy in the living human brain. Psychopharmacology (Berl) 1993;110:265-272
7. Tauscher J, Kapur S. Choosing the right dose of antipsychotics in schizophrenia: lessons from neuroimaging studies. CNS Drugs 2001;15:671-678
8. Farde L, Nordstrom AL, Wiesel FA, et al. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine: relation to extrapyramidal side effects. Arch Gen Psychiatry 1992;49:538-544
9. Tauscher-Wisniewski S, Kapur S, Tauscher J, et al. Quetiapine: an effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockade. J Clin Psychiatry 2002;63:992-997